×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| TAKE SOLUTIONS LTD. | 0.06 | -21.65 | 0.0 | -0.15 | 166.0 | 63.7 |
| PARNAX LAB LTD. | NA | NA | NA | NA | 161 | 14.9 |
| LACTOSE (INDIA) LTD. | NA | NA | NA | NA | 160 | 36.4 |
Take Solutions Ltd, with Security Code 532890, is a leading player in the Healthcare Research- Analytics & Technology industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2021 | Dec 2021 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.0 | 9.0 | 14.8 | 5.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Expenses | 3.0 | 12.5 | 12.1 | 4.4 | 1.1 | 1.5 | 7.9 | 0.8 | 0.7 | 2.0 |
| Operating Profit | -3.0 | -3.5 | 2.7 | 1.0 | -1.1 | -1.5 | -7.9 | -0.8 | -0.7 | -2.0 |
| OPM % | 0% | -38.5% | 18.35% | 18.56% | 0% | 0% | 0% | 0% | 0% | 0% |
| Other Income | 4.2 | 3.3 | 2.0 | -0.3 | 0.1 | 0.7 | -192.8 | 2.9 | 10.9 | 0.0 |
| Interest | 0.1 | 0.1 | 0.5 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
| Depreciation | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | 0.8 | -0.5 | 9.5 | 0.5 | -1.4 | -1.1 | -20.6 | 1.9 | 10.0 | -2.2 |
| Tax % | 11.6% | 3.1% | 2.8% | -111.7% | -24.1% | 333.7% | 0.3% | 0% | 0% | 0% |
| Net Profit | 0.9 | -0.5 | 4.1 | 0.0 | -1.1 | -4.6 | -201.5 | 0.9 | 4.8 | -2.2 |
| EPS in Rs | 0.06 | -0.03 | 0.28 | -0.07 | -0.31 | -13.62 | 0.06 | 0.32 | -0.15 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 44.9 | 53.6 | 37.5 | 17.5 | 18.1 | 16.9 | 13.2 | 0.0 | 0.0 | 0.0 |
| Expenses | 71.7 | 56.4 | 26.5 | 18.7 | 16.3 | 15.7 | 28.4 | 2.2 | 1.2 | 2.9 |
| Operating Profit | -26.8 | -2.8 | 11.0 | -1.2 | 1.8 | 1.1 | -15.2 | -2.2 | -1.2 | -2.9 |
| OPM % | -59.63% | -5.22% | 29.29% | -6.83% | 9.97% | 6.73% | -115.24% | 0% | 0% | 0% |
| Other Income | 4.0 | 1.4 | -9.0 | -0.1 | 0.1 | 1.1 | -92.8 | 0.0 | 0.0 | 8.5 |
| Interest | 1.3 | 1.3 | 3.9 | 1.5 | 1.4 | 1.3 | 1.2 | 0.5 | 0.5 | 0.7 |
| Depreciation | 5.0 | 4.8 | 4.3 | 2.3 | 2.2 | 1.9 | 1.6 | 0.0 | 0.0 | 0.0 |
| Profit before tax | -29.0 | -7.5 | 1.0 | -4.7 | -1.6 | -1.0 | -17.9 | -2.7 | -1.7 | 4.9 |
| Tax % | -0.1% | 30.8% | -1.7% | 5.1% | -3.8% | 123.9% | -0.1% | 2.1% | -3.3% | 0% |
| Net Profit | -8.2 | -9.9 | -56.0 | -5.3 | -1.5 | -2.1 | -110.6 | -3.7 | -1.6 | 47.7 |
| EPS in Rs | -0.55 | -0.7 | -3.83 | -0.36 | -0.11 | -0.15 | -7.56 | -0.26 | -0.11 | 3.26 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -15% |
| 5 Years: | -24% |
| 3 Years: | -20% |
| TTM: | -96% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -705% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -21% |
| 5 Years: | -28% |
| 3 Years: | -25% |
| 1 Year: | -60% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -22% |
| 5 Years: | -50% |
| 3 Years: | -56% |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 24% |
| TTM: | -40% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -21% |
| 5 Years: | -28% |
| 3 Years: | -25% |
| 1 Year: | -60% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|